MARLBOROUGH, Mass., Aug. 2, 2018 /PRNewswire/ — RXi Pharmaceuticals Corporation (NASDAQ: RXII) a biotechnology company developing the next generation of immuno-oncology therapeutics based on its prop…
( read original story …)
The Japan News
MARLBOROUGH, Mass., Aug. 2, 2018 /PRNewswire/ — RXi Pharmaceuticals Corporation (NASDAQ: RXII) a biotechnology company developing the next generation of immuno-oncology therapeutics based on its prop…
( read original story …)